At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 114 enrolled
Drug / intervention
MR-107A-01 +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Double Blind, Placebo-Controlled, Parallel Group, Dose-Response Study of MR-107A-01 in The Treatment of Post-Surgical Dental Pain
In Brief
A Phase 2 clinical trial evaluating MR-107A-01 and Placebo for Pain and 2 related conditions. Completed, enrolled 114 participants across 1 site.
Detailed Summary
MR-107A-01 is being studied to investigate its efficacy, safety, and dose-response after dental surgery.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain, Postoperative Pain, Pain, Acute
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
202120222023202420252026
Enrollment StartSep 2020
First PostedOct 2020
Primary CompletionDec 2020
Study CompletionDec 2020
TodayJul 2026
First PostedOct 1, 2020
Enrollment StartSep 29, 2020
Primary CompletionDec 15, 2020
Study CompletionDec 22, 2020
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 5.8 years ago
Interventions
MR-107A-01drug
Oral tablet
Placebodrug
Oral tablet